Checking in on RFK Jr.’s promises, one year later
Stat News • 2/17/2026
Summary
The news story titled "Checking in on RFK Jr.’s promises, one year later" reviews the commitments made by RFK Jr. over the past year. It is part of the Morning Rounds newsletter, which also includes other health news.
Advertisement
Lindy Score Breakdown (V4.2)
46d
Age
1
Sources
from cluster
1106
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1106/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1106/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 46 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
STAT+: Makary marks one year at FDA with focus on achievements in speech to staff
Stat News • 2 days ago
STAT+: Beyond detection: In the age of clinical AI, what counts as an FDA ‘breakthrough’ medical device?
Stat News • 2 days ago
Opinion: Medical misinformation wins when patients can’t see their doctors
Stat News • 2 days ago
Thursday was World Autism Awareness Day. HHS celebrated with…a workout?
Stat News • 1 day ago
Opinion: Subscription pricing could expand access to HIV prevention breakthrough while controlling costs
Stat News • 1 day ago
STAT+: Trump announces 100% tariffs on brand-name drugs, with plenty of carveouts
Stat News • 1 day ago
Biotech investors’ plea to Trump, and a busy M&A week
Stat News • 1 day ago
STAT+: FDA’s evolving view of what makes a ‘breakthrough’ device
Stat News • 1 day ago
STAT+: Up and down the ladder: The latest comings and goings
Stat News • 1 day ago
STAT+: White House proposes 12% cut to federal health agencies in 2027 budget request
Stat News • 1 day ago
Anti-Lindy Similar stories
STAT+: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more
Stat News • 5 days ago
STAT+: FDA approves Denali Therapeutics drug for Hunter syndrome
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about a Merck acquisition, the rise of former Loxo execs at Lilly, and more
Stat News • 1 week ago
STAT+: Pharmalittle: We’re reading about an FDA OK for a rare disease drug, a grilling of the PTO chief, and more
Stat News • 1 week ago